Pharmaceutical

Successor to Vioxx fails to quell concerns

When drug company Merck revealed the the results of a study this week over it's successor to Vioxx, the new arthritis drug Arcoxia, it did little to quell concerns about both the use and the safety of the new drug.Both Vioxx and Arcoxia are painkillers known as Cox-2 inhibitors; Vioxx was withdrawn from the market in September 2004, after a study found it doubled heart attack and stroke risks.In the largest-ever trial of an arthritis drug, ...Wednesday, 15-Nov-2006 / [ Details... ]

Approval of orlistat capsules over-the-counter

The U.S. Food and Drug Administration (FDA) today approved orlistat capsules as an over-the-counter (OTC) weight loss aid for overweight adults. Orlistat was initially approved in 1999 as a prescription drug to treat obesity, and remains a prescription drug for obesity at a higher dose than the OTC version. OTC orlistat will be manufactured by GlaxoSmithKline under the name Alli and is indicated ...Wednesday, 7-Feb-2007 / [ Details... ]

FDA warns of deadly results of skin-numbing creams

The U.S. Food and Drug Administration (FDA) has issued a warning about topical anesthetics that have skin-numbing effects.Topical anesthetics are most commonly used for cosmetic procedures and to relieve burning and itching and they contain anesthetic drugs such as lidocaine, tetracaine, benzocaine, and prilocaine in a cream, ointment, or gel form.The FDA says such products can cause serious and life-threatening side effects such as irregular...Wednesday, 7-Feb-2007 / [ Details... ]

Research helps explain origin of self-reactive B cells

Doctors have long wondered why, in some people, the immune system turns against parts of the body it is designed to protect, leading to autoimmune disease. Now, researchers at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), in collaboration with the Oklahoma Medical Research Foundation, have provided some new clues into one likely factor: the early development...Wednesday, 7-Feb-2007 / [ Details... ]

ViroPharma receives orphan drug designation for Maribavir

ViroPharma Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for maribavir for prevention of cytomegalovirus (CMV) viremia and disease in the populations at-risk. The Orphan Drug Act was designed to provide incentives to companies to develop drugs that treat conditions affecting 200,000 or fewer patients annually in the U.S. and tha...Wednesday, 7-Feb-2007 / [ Details... ]

WHO cautions Thailand against issuing compulsory license for antiretroviral Kaletra

The World Health Organization on Thursday cautioned the Thai government on its decision to allow the country to produce a lower-cost version of Abbott Laboratories' antiretroviral drug Kaletra by granting a compulsory license for the drug, the Bangkok Post reports (Treerutkuarkul, Bangkok Post, 2/2). Thailand's ...Wednesday, 7-Feb-2007 / [ Details... ]

Canadian prescription drugs still being seized in U.S.

At least 37 packages of prescription drugs from Canada were seized by federal officials in South Florida, despite a federal government promise in October 2006 to stop confiscating drugs imported for personal use, the South Florida ...Wednesday, 7-Feb-2007 / [ Details... ]

Ban called for on newer birth control pills

The advocacy group Public Citizen has filed a petition with the Food and Drug Administration (FDA) demanding that the sale of some of the newer birth control pills be banned.The group says some of them almost double the risk of life-threatening blood clots compared to older forms of birth control pills and should be taken off market.All contraceptive pills are known to carry some risk of blo...Tuesday, 6-Feb-2007 / [ Details... ]

Ranbaxy and GlaxoSmithKline form alliance

Ranbaxy Laboratories announced today that the Company and GlaxoSmithKline have signed a new, multiyear R&D agreement that modifies and expands the terms of their strategic alliance established in 2003 to provide Ranbaxy expanded drug-development responsibilities and further financial opportunities. Under the original agreement, Ranbaxy conducted the optimization chemistry required to progress ...Tuesday, 6-Feb-2007 / [ Details... ]

Many low-income Medicare beneficiaries receive no help from PAPs

Many low-income Medicare beneficiaries enrolled in the prescription drug benefit receive no help from patient assistance programs operated by pharmaceutical companies, according to advocacy groups, USA Today reports. Many pharmace...Tuesday, 6-Feb-2007 / [ Details... ]


...Prev  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next...
Total: 1467


 
© 2006, DrPlace.com, All Rights Reserved.